{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04644",
    "Peptide Name": "Retrocd4 (cyclic dimeric KR-12, synthetic AMPs, UCBB1; Derivative: retro-ld*)",
    "Source": "designed, human cathelicidin analog, animal-derived, natural derivative",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "AGGKRIVQRIKDFLRGAGGRLFDKIRQVIRKG",
    "Sequence Length": 32,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Antifungal",
      "candidacidal"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 8,
    "Boman Index": 2.73,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "38%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is similar (67.57%) tocd4K: 13%, R: 19%, I: 13%, G: 19%.Activity:  active against E. coli (MIC 1.25 uM), P. aeruginosa (MIC 0.625 uM), S. aureus (MIC 1.25  uM), and C. albicans (MIC 2.5  uM). Warning: Non-standard assay.SAR: the linear form of this peptide has activity similar to the cyclic form.",
    "Author": "Gunasekera S, Muhammad T, Strömstedt AA, Rosengren KJ, Göransson U.2020",
    "Reference": "Front Microbiol. 2020 Feb 21;11:168. doi: 10.3389/fmicb.2020.00168.PubMed",
    "Title": "Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability."
  },
  "3D Structure": []
}